300841 logo

Chengdu Kanghua Biological Products Co., Ltd. Stock Price

SZSE:300841 Community·CN¥6.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300841 Share Price Performance

CN¥48.50
-41.29 (-45.99%)
CN¥48.50
-41.29 (-45.99%)
Price CN¥48.50

300841 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and fair value.

1 Risk
3 Rewards

Chengdu Kanghua Biological Products Co., Ltd. Key Details

CN¥1.2b

Revenue

CN¥108.8m

Cost of Revenue

CN¥1.1b

Gross Profit

CN¥864.2m

Other Expenses

CN¥226.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 18, 2026
1.74
90.93%
18.89%
0.8%
View Full Analysis

About 300841

Founded
2004
Employees
550
CEO
Hongbo Wu
WebsiteView website
www.kangh.com

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, and operation of biological products in China. It offers freeze-dried human rabies vaccines; ACYW135 meningococcal polysaccharide vaccine. The company was founded in 2004 and is based in Chengdu, China.

Recent 300841 News & Updates

Recent updates

No updates